文献速递慢性肾脏病肾血管病与高血压

硫酸吲哚酚通过E3连接酶SHFM3稳定IDO1促进尿毒症动静脉血栓形成

Indoxyl Sulfate Promotes Uremic Arterial and Venous Thrombosis by Stabilizing IDO1 via the E3 Ligase SHFM3.
PubMed 文献 · J Am Soc Nephrol · 2026-08-21

本研究探讨硫酸吲哚酚介导IDO1稳定的机制。在CKD小鼠模型中,硫酸吲哚酚通过诱导SHFM3核隔离,部分破坏SHFM3与IDO1的相互作用,从而稳定IDO1并增加犬尿氨酸生成,促进动脉和静脉血栓形成。SHFM3过表达可逆转上述效应,且血清硫酸吲哚酚水平与IDO1活性和静脉血栓重量相关。

要点

  • SHFM3是IDO1的E3连接酶,泛素化并降解IDO1。
  • 硫酸吲哚酚诱导SHFM3核隔离,减少其与IDO1结合,稳定IDO1。
  • 内皮细胞SHFM3过表达可减轻CKD相关动静脉血栓形成。

核心结论

  • SHFM3作为硫酸吲哚酚敏感的E3连接酶,靶向降解IDO1,在尿毒症环境中部分相互作用,支持尿毒症毒素翻译后蛋白质稳态重编程放大血栓形成。

研究设计与样本

  • 采用靶向代谢组学、超分辨显微镜和功能获得/缺失实验,通过纳米颗粒介导的基因递送在小鼠中调节SHFM3表达,随后在硫酸吲哚酚喂养和腺嘌呤诱导的CKD模型中进行颈动脉或下腔静脉血栓形成实验。

主要发现

  • 在含F-box的E3连接酶中,SHFM3下调内皮细胞IDO1;SHFM3与IDO1组成性相互作用,硫酸吲哚酚诱导SHFM3核隔离部分破坏该相互作用。
  • SHFM3与IDO1 N端相互作用,泛素化并使其不稳定;硫酸吲哚酚以N端和SHFM3依赖的方式上调IDO1活性,增加犬尿氨酸生成。
  • 在硫酸吲哚酚喂养小鼠中,内皮细胞特异性SHFM3敲低增加IDO1和组织因子并加速动脉血栓形成,SHFM3过表达逆转这些效应。
  • CKD小鼠静脉血栓形成性比对照组高55%;内皮细胞特异性SHFM3过表达显著逆转对照小鼠中的效应,在CKD小鼠中逆转程度较小。
  • 血清硫酸吲哚酚水平与整体IDO1活性和静脉血栓重量显著相关。

临床怎么用

  • 靶向内皮细胞SHFM3-IDO1轴可能减轻CKD相关动静脉血栓形成。
  • 血清硫酸吲哚酚水平或可辅助评估血栓风险。

局限性

  • 研究主要基于小鼠模型,人类临床验证尚未进行。
  • SHFM3过表达在CKD小鼠中逆转效应程度较小,提示尿毒症环境存在其他机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The uremic milieu of chronic kidney disease (CKD) is characterized by the accumulation of protein-bound uremic toxins, which contribute to thrombosis. Indoxyl sulfate, a bona fide uremic toxin, upregulates indoleamine 2,3-dioxygenase 1 (IDO1), thereby augmenting kynurenine biogenesis. Both toxins activate tissue factor and thrombosis. Despite this pathogenic synergy, the mechanisms of indoxyl sulfate-mediated IDO1 stabilization remain undefined. METHODS: We employed targeted metabolomics, super-resolution microscopy, and gain-and loss-of-function experiments using nanoparticle-mediated gene delivery in mice to modulate SHFM3 expression. This was followed by carotid artery or inferior vena cava thrombosis assays in indoxyl sulfate-fed and adenine-induced CKD models. RESULTS: Among several F-box-containing E3 ligases, split-hand/foot malformation 3 (SHFM3) downregulates IDO1 in endothelial cells. SHFM3 constitutively interacts with IDO1, which is partially disrupted by indoxyl sulfate-induced nuclear sequestration of SHFM3 at concentrations corresponding to early to advanced CKD. SHFM3 interacts with the N-terminus of IDO1, ubiquitinates and destabilizes it. Indoxyl sulfate upregulates IDO1 activity, thereby increasing kynurenine biogenesis in N-terminus- and SHFM3-dependent manners. In an indoxyl sulfate-fed mouse model, endothelial cell-specific SHFM3 knockdown increased IDO1 and tissue factor and accelerated arterial thrombosis, and these effects were reversed by endothelial cell-specific SHFM3 overexpression. CKD mice exhibited 55% higher venous thrombogenicity than controls. Endothelial cell-specific SHFM3 overexpression significantly reversed these effects in control mice and to a lesser extent in CKD mice. Serum indoxyl sulfate levels significantly correlated with the global IDO1 activity and venous clot weights. CONCLUSIONS: SHFM3 functions as an indoxyl sulfate-sensitive potent E3 ligase of IDO1, targeting it for degradation, even with partial interaction with IDO1 in the uremic milieu. This work also described CKD-induced venous thrombosis model and supports the selective rewiring of uremic toxins in post-translational proteostasis, amplifying indoxyl sulfate-mediated arterial and venous thrombosis.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Almiron R, Malloum AB, Lotfollahzadeh S, et al. Indoxyl Sulfate Promotes Uremic Arterial and Venous Thrombosis by Stabilizing IDO1 via the E3 Ligase SHFM3. J Am Soc Nephrol. 2026. PMID: 42627700. doi:10.1681/ASN.0000001203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。